These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2309947)

  • 21. Patterns of cerebral glucose metabolism using 18FDG and positron tomography in the neurologic investigation of the full term newborn infant.
    Thorp PS; Levin SD; Garnett ES; Nahmias C; Firnau G; Toi A; Upton AR; Nobbs PT; Sinclair JC
    Neuropediatrics; 1988 Aug; 19(3):146-53. PubMed ID: 3265490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crossed cerebellar and uncrossed basal ganglia and thalamic diaschisis in Alzheimer's disease.
    Akiyama H; Harrop R; McGeer PL; Peppard R; McGeer EG
    Neurology; 1989 Apr; 39(4):541-8. PubMed ID: 2784550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional brain function in schizophrenia. I. A positron emission tomography study.
    Gur RE; Resnick SM; Alavi A; Gur RC; Caroff S; Dann R; Silver FL; Saykin AJ; Chawluk JB; Kushner M
    Arch Gen Psychiatry; 1987 Feb; 44(2):119-25. PubMed ID: 3492982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic [18F]fluorodeoxyglucose positron emission tomography and hypometabolic zones in seizures: reduced capillary influx.
    Cornford EM; Gee MN; Swartz BE; Mandelkern MA; Blahd WH; Landaw EM; Delgado-Escueta AV
    Ann Neurol; 1998 Jun; 43(6):801-8. PubMed ID: 9629850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [No hypofrontality in schizophrenia demonstrated by positron emission tomography].
    Biver F; Delvenne V; Goldman S; Luxen A; De Maertelaer V; Lotstra F; Mendlewicz J
    Acta Psychiatr Belg; 1992; 92(5):261-78. PubMed ID: 1345405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basal ganglia and frontal lobe glucose metabolism. A reproducibility positron emission tomography study.
    Goldman S; Dethy S; Lotstra F; Biver F; Stanus E; Wikler D; Hildebrand J; Mendlewicz J; Luxen A
    J Neuroimaging; 1995 Oct; 5(4):219-26. PubMed ID: 7579750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebral glucose metabolic differences in patients with panic disorder.
    Nordahl TE; Semple WE; Gross M; Mellman TA; Stein MB; Goyer P; King AC; Uhde TW; Cohen RM
    Neuropsychopharmacology; 1990 Aug; 3(4):261-72. PubMed ID: 2400544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral glucose utilization during sleep in Landau-Kleffner syndrome: a PET study.
    Maquet P; Hirsch E; Dive D; Salmon E; Marescaux C; Franck G
    Epilepsia; 1990; 31(6):778-83. PubMed ID: 1700954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary data on the metabolic brain pattern of patients with winter seasonal affective disorder.
    Cohen RM; Gross M; Nordahl TE; Semple WE; Oren DA; Rosenthal N
    Arch Gen Psychiatry; 1992 Jul; 49(7):545-52. PubMed ID: 1627045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The metabolic topography of normal aging.
    Moeller JR; Ishikawa T; Dhawan V; Spetsieris P; Mandel F; Alexander GE; Grady C; Pietrini P; Eidelberg D
    J Cereb Blood Flow Metab; 1996 May; 16(3):385-98. PubMed ID: 8621743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Regional cerebral glucose metabolism associated with ataxic gait--an FDG-PET activation study in patients with olivopontocerebellar atrophy].
    Mishina M; Senda M; Ohyama M; Ishii K; Kitamura S; Terashi A
    Rinsho Shinkeigaku; 1995 Nov; 35(11):1199-204. PubMed ID: 8720328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method.
    Schmidt K; Lucignani G; Moresco RM; Rizzo G; Gilardi MC; Messa C; Colombo F; Fazio F; Sokoloff L
    J Cereb Blood Flow Metab; 1992 Sep; 12(5):823-34. PubMed ID: 1506447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain serotonin 1A receptor binding in bulimia nervosa.
    Tiihonen J; Keski-Rahkonen A; Löppönen M; Muhonen M; Kajander J; Allonen T; Någren K; Hietala J; Rissanen A
    Biol Psychiatry; 2004 Apr; 55(8):871-3. PubMed ID: 15050870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography.
    Eidelberg D; Moeller JR; Ishikawa T; Dhawan V; Spetsieris P; Chaly T; Belakhlef A; Mandel F; Przedborski S; Fahn S
    Neurology; 1995 Nov; 45(11):1995-2004. PubMed ID: 7501148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 18Fluorodeoxyglucose positron emission tomography studies in presumed Alzheimer cases, including 13 serial scans.
    McGeer EG; Peppard RP; McGeer PL; Tuokko H; Crockett D; Parks R; Akiyama H; Calne DB; Beattie BL; Harrop R
    Can J Neurol Sci; 1990 Feb; 17(1):1-11. PubMed ID: 2311010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain hypometabolism of glucose in anorexia nervosa: a PET scan study.
    Delvenne V; Lotstra F; Goldman S; Biver F; De Maertelaer V; Appelboom-Fondu J; Schoutens A; Bidaut LM; Luxen A; Mendelwicz J
    Biol Psychiatry; 1995 Feb; 37(3):161-9. PubMed ID: 7727624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gilles de la tourette syndrome: studies with the fluorine-18-labeled fluorodeoxyglucose positron emission tomographic method.
    Chase TN; Foster NL; Fedio P; Brooks R; Mansi L; Kessler R; Di Chiro G
    Ann Neurol; 1984; 15 Suppl():S175. PubMed ID: 6611119
    [No Abstract]   [Full Text] [Related]  

  • 38. Regional cerebral glucose metabolic rate in human sleep assessed by positron emission tomography.
    Buchsbaum MS; Gillin JC; Wu J; Hazlett E; Sicotte N; Dupont RM; Bunney WE
    Life Sci; 1989; 45(15):1349-56. PubMed ID: 2796606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18.
    Baxter LR; Phelps ME; Mazziotta JC; Schwartz JM; Gerner RH; Selin CE; Sumida RM
    Arch Gen Psychiatry; 1985 May; 42(5):441-7. PubMed ID: 3872649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discordance between F-18 fluorodeoxyglucose uptake and contrast enhancement in a brain abscess.
    Meyer MA; Frey KA; Schwaiger M
    Clin Nucl Med; 1993 Aug; 18(8):682-4. PubMed ID: 8403702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.